Teva Pharmaceutical Industries Ltd- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd 是一家總部位於以色列的製藥公司。該公司通過三個部門運營：北美、歐洲和國際市場。每個業務部門管理其所在地區的整個產品組合，包括仿製藥、特種產品和非處方 (OTC) 產品。除了這三個部門之外，該公司還開展其他業務，主要是向第三方銷售活性藥物成分 (API)、某些合同製造服務以及通過其附屬公司 Medis 向其他製藥公司提供產品組合的對外授權平臺。

公司簡介

公司代碼TEVA

公司名稱Teva Pharmaceutical Industries Ltd

上市日期Jan 01, 1951

成立日期1944

CEOMr. Richard D. Francis

員工數量33892

證券類型Ordinary Share

年結日Jan 01

公司地址124 Dvora Hanevi'a St.

城市TEL AVIV-YAFO

上市交易所Tel Aviv Stock Exchange

國家Israel

郵編6944020

電話97239148213

網址https://www.tevapharm.com/

公司代碼TEVA

上市日期Jan 01, 1951

成立日期1944

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Prof. Varda Shalev

Independent Director

12.87K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

名稱

名稱/職務

職務

持股

持股變動

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Prof. Varda Shalev

Independent Director

12.87K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

地區USD

名稱

營收

佔比

United States

8.03B

48.56%

Europe

5.10B

30.85%

International Markets

2.46B

14.89%

Other

944.00M

5.71%

業務

地區

業務USD

名稱

營收

佔比

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

股東統計

更新時間: 19 小時前

持股股東

股東類型

持股股東

股東統計

佔比

Fidelity Management & Research Company LLC

6.63%

Clal Insurance Enterprises Holdings Ltd.

3.40%

Ion Asset Management Israel Ltd

3.20%

BlackRock Institutional Trust Company, N.A.

2.89%

Menora Mivtachim Insurance Ltd.

2.47%

Other

81.42%

持股股東

股東統計

佔比

Fidelity Management & Research Company LLC

6.63%

Clal Insurance Enterprises Holdings Ltd.

3.40%

Ion Asset Management Israel Ltd

3.20%

BlackRock Institutional Trust Company, N.A.

2.89%

Menora Mivtachim Insurance Ltd.

2.47%

Other

81.42%

股東類型

股東統計

佔比

Investment Advisor

25.91%

Investment Advisor/Hedge Fund

13.09%

Hedge Fund

12.84%

Insurance Company

4.75%

Research Firm

2.36%

Pension Fund

1.85%

Bank and Trust

0.94%

Family Office

0.81%

Sovereign Wealth Fund

0.20%

Other

37.25%

機構持股

更新時間: 1月20日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

1071

683.47M

59.65%

-18.19M

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

2023Q1

927

576.84M

51.93%

-50.26M

2022Q4

946

573.39M

51.61%

-69.40M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Fidelity Management & Research Company LLC

76.01M

6.63%

+14.91M

+24.41%

Dec 31, 2024

Clal Insurance Enterprises Holdings Ltd.

38.96M

3.4%

+4.42M

+12.79%

Dec 31, 2024

Ion Asset Management Israel Ltd

36.65M

3.2%

+409.78K

+1.13%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

33.10M

2.89%

+786.74K

+2.43%

Dec 31, 2024

Menora Mivtachim Insurance Ltd.

28.38M

2.48%

-456.80K

-1.58%

Dec 31, 2024

Lingotto Investment Management LLP

27.19M

2.37%

+688.86K

+2.60%

Dec 31, 2024

Migdal Insurance and Financial Holdings Ltd

26.04M

2.27%

+569.41K

+2.24%

Dec 31, 2024

Phoenix Investment and Finances Ltd

21.21M

1.85%

-1.35M

-5.98%

Dec 31, 2024

State Street Global Advisors (US)

19.41M

1.69%

-86.64K

-0.44%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

VanEck Israel ETF

7.39%

iShares MSCI Israel ETF

7.06%

VanEck Pharmaceutical ETF

4.4%

Tema Neuroscience and Mental Health ETF

4.26%

Amplify Weight Loss Drug & Treatment ETF

3.49%

AdvisorShares Dorsey Wright ADR ETF

2.35%

ARK Israel Innovative Technology ETF

1.46%

Amplify International Enhanced Dividend Income ETF

1.33%

FIS Christian Stock Fund ETF

0.91%

Affinity World Leaders Equity ETF

0.9%

VanEck Israel ETF

佔比7.39%

iShares MSCI Israel ETF

佔比7.06%

VanEck Pharmaceutical ETF

佔比4.4%

Tema Neuroscience and Mental Health ETF

佔比4.26%

Amplify Weight Loss Drug & Treatment ETF

佔比3.49%

AdvisorShares Dorsey Wright ADR ETF

佔比2.35%

ARK Israel Innovative Technology ETF

佔比1.46%

Amplify International Enhanced Dividend Income ETF

佔比1.33%

FIS Christian Stock Fund ETF

佔比0.91%

Affinity World Leaders Equity ETF

佔比0.9%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Teva Pharmaceutical Industries Ltd

15.470USD

Teva Pharmaceutical Industries Ltd

15.470

概覽

公司